Shilpa Medicare's Revenue Rises By 63% Aided By API Segment

(1:12)

Shilpa Medicare Under Scanner, USFDA \u0026 EU Conduct Audit Of Raichur Unit

(2:7)

Shilpa Medicare

(4:22)

Shilpa Medicare's Telangana Facility Gets Health Canada Approval | Bazaar Corporate Radar |CNBC-TV18

(1:1econd)

Shilpa Medicare Ltd Q1 FY2024-25 Earnings Conference Call

(1:7:35)

Reducing API dependence on China | Shilpa Medicare | Sundeip Bhatia to ET Now

(9:30)

Making IT Big Season 7 Ep#6 Shilpa Medicare

(22:43)

Shilpa Medicare Surges After Positive Clinical Trial From CDMO Customer For Chronic Kidney Disease

(2:19)

Shilpa Medicare's Key CDMO Customer Shows Positive Clinical Results For A Kidney Disease Drug

(2:18)

Plan G downsides - is it really the BEST Medigap plan?

(8:57)

Medicare Supplement Plans With Extra Benefits

(12:27)

Medicare Coverage in 2024: What You Need to Know

(1:6:50)

Medicare-Explained Parts A \u0026 B (Advantage vs Supplement)

(46:14)

Top 2 Pharma MidCap Stocks | CA Rachana Ranade

(16:35)

Medicare Director Dr. Meena Seshamani on Negotiating Drug Prices \u0026 Empowering Community Health Care

(32:27)

Shilpa Medicare Surge In Trade After Receiving US FDA Nod For Arthritis Drug | CNBC-TV18

(1:32)

Shilpa Medicare Gets CDSCO Approval For Tranexamic Acid Spray | Midcap Radar | CNBC-TV18

(2:56)

Cement Sector's Q1 Result Preview | Mindtree, Shilpa Medicare Stocks In Focus | Morning Trade

(23:26)

Shilpa Rout Shares Her Top Trading Ideas \u0026 Market Outlook | Chartbusters | CNBC-TV18

(4:31)

Tata Group, M\u0026M Financial Services, Hero Motocorp, Shilpa Medicare; Key Stocks In Focus Today

(1:30)

Shilpa Medicare || USFDA 483 Observations || April 2022 ||

(5:53)

Customer Testimonial | Shilpa Medicare Ltd | ESDS

(1:33)

Shilpa Medicare Ltd Q3 FY2024-25 Earnings Conference Call

(1:7:54)

AstraZeneca Pharma, Themis Medicare, PG Electroplast, Shilpa Medicare in Focus | Stocks On Radar

(3:2)

Nomura Initiates Buy On Macrotech, Antique Bullish On Shilpa Medicare, Emkay Positive On Stovekraft

(1:28)

Shilpa Medicare, Max Health \u0026 Concord Biotech Rally On Positive Brokerage Notes | CNBC TV18

(1:47)

Shilpa Medicare Business Update Call

(17:34)

Shilpa Medicare's Vishnukant Bhutada Speaks On CDSCO Approval For Hemostatic Spray | Chartbusters

(11:31)

Shilpa Medicare Approaches 52-Week High Of ₹677/Sh; Update On CDMO Arrangement Awaited

(1:6)

Shilpa Medicare Buzzing After UK Drug Regulator Approves Drug Used To Treat Vertigo | CNBC TV18

(1:59)